Speaker:

I mean, as James said, we see lots of headaches, I'm sure you also do,

Speaker:

and there are actually things we can do to help our patients and improve their quality of life.

Speaker:

In common headaches are migraines and tension headaches. The vast majority of

Speaker:

headaches do not correspond to a serious pathology, but it's a leading cause of disability.

Speaker:

So non-life-threatening headaches are very common, but they remain disabling and costly.

Speaker:

So let's have a look at a few cases. So the first patient is Josephine.

Speaker:

She's 35 and she has very stereotyped headaches, usually once a month.

Speaker:

And sometimes she gets a little bit of a run of them with several per week.

Speaker:

It usually starts with a disturbed vision blurring in the left eye and a feeling

Speaker:

that the vision from the left eye is bright.

Speaker:

And about 10 minutes after the visual symptoms started, they get better and she has a headache.

Speaker:

She's a bad unilateral throbbing headache.

Speaker:

The headache grows in intensity and she feels nauseated.

Speaker:

If she takes any action, the headache lasts two to four hours and slowly remits

Speaker:

and she feels washed out afterwards.

Speaker:

So I'm sure you have seen some of these patients before. So what is this?

Speaker:

I mean, this very much looks like a migraine.

Speaker:

So someone who has a visual aura first and then develops a headache,

Speaker:

severe headache, unilateral thrubbing associated with nausea.

Speaker:

The nature of the visual disturbance also tells you that it's most likely a

Speaker:

migraine. That's what we will call positive visual disturbance.

Speaker:

So someone described the vision as being bright or zigzags or watery vision,

Speaker:

as opposed to someone who has a stroke who will say, I lost the vision in the right eye.

Speaker:

So there, when you take the history and examine the patient,

Speaker:

one of the things to ask is they try to cover one eye. Is this hemivisual field

Speaker:

or is it happening just in one eye?

Speaker:

So now we talk a bit about what we do and how quickly we should treat and whether

Speaker:

we should do brain imaging.

Speaker:

Before I come to the treatment, I want to just talk about imaging.

Speaker:

When do we do brain imaging? I guess probably as neurologists,

Speaker:

we might be doing more brain imaging than you do. I tend to do a brain imaging

Speaker:

when I see a new patient with headaches, even if it's typical of migraine.

Speaker:

I like having a brain imaging.

Speaker:

And then, obviously, if there is any concerns that it's not a typical headache

Speaker:

or if the typical headache changes.

Speaker:

So things to worry about. When do we worry that can be something else?

Speaker:

So there are a few examples here.

Speaker:

If the patient has a known cancer or systemic condition, you might worry that

Speaker:

this could correspond to a brain metastasis.

Speaker:

Someone over 50 with a temporal pain might worry about giant cell arthritis.

Speaker:

Anyone who has abnormal signs on clinical examination, is there an intracranial process.

Speaker:

I mean, someone who has a new headache over 50 is always someone we would be concerned about.

Speaker:

Tunderclap headaches, which peak in intensity in less than one minute,

Speaker:

very important. We have to think about subarachnoid hemorrhage.

Speaker:

And then other types of headaches related to changes in intracranial pressure,

Speaker:

like whether they have associated pulsatile tinnitus, whether the headache is positional,

Speaker:

whether there are visual changes and papillary dema and clinical examination

Speaker:

should definitely raise possible diagnosis of increased intracranial pressure.

Speaker:

Some other headaches precipitated by Valsalva might make you think about a mass

Speaker:

lesion or carrie malformation.

Speaker:

So there is this acronym which was suggested in one of the journals that neurologists

Speaker:

read, which is called Practical Neurology. So that's a SNOOP acronym.

Speaker:

So these are kind of warning signs.

Speaker:

If you have some of these, you might have to think about the secondary headache

Speaker:

and organized brain imaging.

Speaker:

So what do we do with migraines? Maybe I'll say what I would do.

Speaker:

Like I would give a gram of aspirin or 800 milligram of ibuprofen.

Speaker:

So a big dose of anti-inflammatory as early as the patient has symptoms.

Speaker:

They have to be quick. Take it very quickly for it to be efficient.

Speaker:

If it doesn't work, combining anti-inflammatory with triptan.

Speaker:

Tryptan seems to have a synergic effect.

Speaker:

So just this little schema shows you that tryptan will act on the cranial vasculature

Speaker:

because we think that when someone has the aura,

Speaker:

there is some constriction of blood vessels causing the neurological symptoms,

Speaker:

and then the blood vessels dilates, causing the headaches.

Speaker:

And one of the key things I've put twice on these slides is we should not be

Speaker:

using opioids for headaches.

Speaker:

It just chronifies the headaches and shouldn't be used on a regular basis.

Speaker:

So in terms of preventative management, one of the things about preventative

Speaker:

management is there are different medications we can try.

Speaker:

And we should try them at a good dose for at least two, three months to know if they work.

Speaker:

Sometimes I see patients who take 10 milligrams of N-DEP, which is okay in terms

Speaker:

of dose, but they only take it when they have a headache.

Speaker:

That doesn't work that way. So every single day for at least two,

Speaker:

three months, keeping your headache diary, and we decide if it works or not.

Speaker:

And we'll give a preventative in someone who has four or more days of migraine per month.

Speaker:

So, the recommended drugs are beta blockers such as propanolol.

Speaker:

Now, Candesartan is one of the medications we can also give in migraines.

Speaker:

Anti-epileptic medications, I mentioned the N-depot or amitriptyline for antidepressants.

Speaker:

I actually realized after I sent these slides that I forgot to put botulinum toxin on this slide.

Speaker:

So, we also use Botox for chronic migraines. and the new drugs,

Speaker:

which are the CGRP monoclonal antibody and the Gapins.

Speaker:

Chronic migraine means more than 15 days of migraine per month.

Speaker:

The medications, so the CGRP antagonists, so amgality,

Speaker:

HIV and viepty, which are the most commonly used, or the only one we have actually in Australia,

Speaker:

and botulinum toxin should only be used in patients who have tried at least

Speaker:

three of the conventional medication and have not responded,

Speaker:

have had potentially bad side effects to them, or have given up, or have...

Speaker:

And then it's only if you have tried three of them and they have failed that

Speaker:

you can prescribe these expensive medications or botulinum toxin.

Speaker:

Lifestyle is important and this little schema there is from the American Migraine

Speaker:

Association, which says sleep, exercise, eat, diary and stress.

Speaker:

So try to manage all these things as well as we can, I guess.

Speaker:

And this will help with symptoms. What's also important is for the patients

Speaker:

to try to identify what, for them,

Speaker:

triggers migraines, like some would know that, for instance,

Speaker:

if they sleep a bit late on the weekend,

Speaker:

they will wake up with a migraine.

Speaker:

Sometimes patients will report changes in atmospheric pressure.

Speaker:

Not much we can do about that one, obviously, but they know that they're more

Speaker:

likely to have a migraine.

Speaker:

And keep a migraine diary or use a migraine app is very useful because,

Speaker:

I mean, we might not remember how last month was.

Speaker:

And there might be just slight changes with medications that we forgot about.

Speaker:

In terms of the CGRP antagonists,

Speaker:

so the CGRP is released by the trigeminal nerve arborization and the receptor

Speaker:

is located on blood vessels.

Speaker:

So the monoclonal antibodies this will act against these proteins and the Gepens, which are here,

Speaker:

which you might have not heard much of these.

Speaker:

I never can... Oh, sorry.

Speaker:

Will act directly on the receptor on the blood vessel.

Speaker:

Currently, the only GEPEND that we have in Australia is a NERTIC,

Speaker:

which unfortunately is not reimbursed.

Speaker:

So it's quite expensive. It's about $30 per tablet.

Speaker:

So if you want to take it as a preventative, you have to take it one every second

Speaker:

day, which obviously is a lot of money.

Speaker:

And then it can also be used in the acute phase as an additional tablet.

Speaker:

So it's a maximum of one tablet per day.

Speaker:

I have to say that these new drugs, Mgality, HIV and ViapT, so the monoclonal

Speaker:

antibody have made a huge difference.

Speaker:

I think for patients with chronic headaches, there wasn't that much we could

Speaker:

do. like this was always a bit of a struggle, they would come back to the clinic

Speaker:

and say, I'm not much better.

Speaker:

But these drugs have been very effective with very good tolerance.

Speaker:

So another case, Ruby is 45 and

Speaker:

I chose two women because unfortunately migraine is more common in women.

Speaker:

So she has a 10-year history of migraine without aura, but over the past year,

Speaker:

her migraine attacks have increased from once a month to several times per week.

Speaker:

So she began taking paracetamol and ibuprofen almost daily, and sometimes using

Speaker:

codeine-containing in combination when the pain was severe.

Speaker:

And she now reports more like a dull, daily pressing headache,

Speaker:

often worse with exertion or stress.

Speaker:

Pain is not as bad as her usual migraine, but this is just there all the time.

Speaker:

And on top of that, she sometimes has her usual migraines.

Speaker:

So, I mean, you might already know what this corresponds to,

Speaker:

but this is also one of the big issues we have with people who have migraines or pain in general.

Speaker:

This is the overuse of entalgics.

Speaker:

So patients who tend to use antalgics for more than 15 days per month are at

Speaker:

risk of chronifying their headaches and develop this more like constant duller type of headache.

Speaker:

And it's often hard to tell them that they have to stop taking these antalgics

Speaker:

all the time because they're in pain all the time.

Speaker:

But it has to happen somewhat quickly, if it's just Panadol or ibuprofen,

Speaker:

a bit slower if there is any codeine-based or opioid medication.

Speaker:

And then we will start them on a preventative medication and reinforce all the

Speaker:

importance of sleep hygiene,

Speaker:

stress management, hydration, and awareness about triggers.

Speaker:

So, I mostly talk about these common types of headaches, but I'm happy to answer

Speaker:

a question you might have about other things in the Q&A.

Speaker:

So, just to summarize, headaches are common and treatable.

Speaker:

History is a key to diagnosis and neurological science are rare.

Speaker:

Acute therapy includes simple analgesic and opioids should be avoided.

Speaker:

And if any concerns, we're always happy to see these patients. Thank you.